Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Aldar S. Bourinbaiar"'
Autor:
Aldar S. Bourinbaiar, Uyanga Batbold, Yuri Efremenko, Munkhburam Sanjagdorj, Dmytro Butov, Narantsetseg Damdinpurev, Elena Grinishina, Otgonbayar Mijiddorj, Mikola Kovolev, Khaliunaa Baasanjav, Tetyana Butova, Natalia Prihoda, Ochirbat Batbold, Larisa Yurchenko, Ariungerel Tseveendorj, Olga Arzhanova, Erkhemtsetseg Chunt, Hanna Stepanenko, Nina Sokolenko, Natalia Makeeva, Marina Tarakanovskaya, Vika Borisova, Alan Reid, Valeryi Kalashnikov, Peter Nyasulu, Satria A. Prabowo, Vichai Jirathitikal, Allen I. Bain, Cynthia Stanford, John Stanford
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 18, Iss , Pp - (2020)
Objective: Immunotherapy of tuberculosis (TB) to shorten treatment duration represents an unmet medical need. Orally delivered, tableted TB vaccine (V7) containing heat-killed Mycobacterium vaccae (NCTC 11659) has been demonstrated in prior clinical
Externí odkaz:
https://doaj.org/article/9aec85cf84b84ec395ea112f96a07a7b
Autor:
Alan A. Reid, Hulan Tsogkhuu, Vichai Jirathitikal, Galyna A Kutsyna, Marina G Tarakanovskaya, Aldar S. Bourinbaiar, Chogsom Munkhzaya, Dandii Oyungerel, Purev Batchuluun, Allen I Bain, Vika Borisova, Dorjiin Dandii, Jigjidsuren Chinburen
Publikováno v:
Hepatoma Research. 2020
Autor:
Galyna A Kutsyna, Genden Purevsuren, Vika Borisova, Aldar S. Bourinbaiar, Purev Batchuluun, Tsogkhuu Hulan, Alan A. Reid, Vichai Jirathitikal, Marina G Tarakanovskaya, Allen I Bain, Jigjidsuren Chinburen, Dorjiin Dandii, Dandii Oyungerel, Chogsom Munkhzaya
Publikováno v:
Journal of Hepatocellular Carcinoma
Marina G Tarakanovskaya,1 Jigjidsuren Chinburen,2 Purev Batchuluun,2 Chogsom Munkhzaya,2 Genden Purevsuren,2 Dorjiin Dandii,3 Tsogkhuu Hulan,3 Dandii Oyungerel,4 Galyna A Kutsyna,5 Alan A Reid,6 Vika Borisova,6 Allen I Bain,7 Vichai Jirathitikal,7 Al
Autor:
Ochirbat Batbold, Larisa V. Yurchenko, Dmytro Butov, Mikola E Kovolev, Vika Borisova, Hanna Stepanenko, Nina I. Sokolenko, Elena A. Grinishina, Natalia D Prihoda, Ariungerel Tseveendorj, Alan A. Reid, Khaliunaa Baasanjav, Uyanga Batbold, Narantsetseg Damdinpurev, Tetyana Butova, Satria A. Prabowo, Munkhburam Sanjagdorj, John Lawson Stanford, Allen I Bain, Erkhemtsetseg Chunt, Cynthia Ann Stanford, Vichai Jirathitikal, Natalia I. Makeeva, Olga Arzhanova, Aldar S. Bourinbaiar, Peter Nyasulu, Yuri V Efremenko, Valeryi Kalashnikov, Marina G Tarakanovskaya, Otgonbayar Mijiddorj
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 18, Iss, Pp-(2020)
Objective: Immunotherapy of tuberculosis (TB) to shorten treatment duration represents an unmet medical need. Orally delivered, tableted TB vaccine (V7) containing heat-killed Mycobacterium vaccae (NCTC 11659) has been demonstrated in prior clinical
Autor:
Uyanga Batbold, Ochirbat Batbold, Dmytro O. Butov, Mikola E Kovolev, Ariungerel Tseveendorj, Aldar S. Bourinbaiar, Galyna A Kutsyna, Vichai Jirathitikal, Svetlana I Zaitzeva, Khaliunaa Baasanjav, Hanna Stepanenko, Erkhemtsetseg Chunt, Peter Nyasulu, Natalia I. Makeeva, Allen I Bain, Narantsetseg Damdinpurev, Tatyana S. Butova, Igor V Mospan, John L Rowe, Marina G Tarakanovskaya, Otgonbayar Mijiddorj, Munkhburam Sandagdorj, Volodymyr S. Pylypchuk, Elena A. Grinishina
Publikováno v:
Immunotherapy. 9(1)
Aim: Safer and shorter antituberculosis treatment (ATT) regimens represent the unmet medical need. Patients & methods: The patients were randomly assigned into two arms: the first (n = 137) received once-daily sublingual honey lozenge formulated with
Autor:
Larisa V. Yurchenko, Galyna A Kutsyna, Natalia D Prihoda, Svetlana I Zaitzeva, Jirathitikal, Tetyana Butova, Aldar S. Bourinbaiar, Yuri V Efremenko, Dmytro Butov, Anna L Stepanenko, Nina I. Sokolenko
Publikováno v:
Immunotherapy. 5:1047-1054
Aim: A 1-month Phase II trial was conducted in 41 patients with pulmonary TB who were randomized into treatment (n = 20) and placebo (n = 21) arms to investigate the safety and efficacy of an orally-administered therapeutic TB vaccine (V7) containing
Autor:
Svetlana I Zaitzeva, Anna L Stepanenko, Larisa V. Yurchenko, Dmytro Butov, Galyna A Kutsyna, Vichai Jirathitikal, Yuri V Efremenko, Natalia D Prihoda, Tetyana Butova, Nina I. Sokolenko, Aldar S. Bourinbaiar
Publikováno v:
Human Vaccines & Immunotherapeutics. 9:1852-1856
One-month Phase II trial was conducted in 43 sputum smear-positive patients with pulmonary tuberculosis randomized into treatment (n = 22) and placebo (n = 21) arms to investigate the safety and efficacy of an orally-administered therapeutic TB vacci
Autor:
Galyna A Kutsyna, Dmytro Butov, Yuri V Efremenko, Nina I. Sokolenko, Larisa I Yurchenko, Svetlana S Zaitzeva, Anna L Stepanenko, Tatiana Butova, Vichai Jirathitikal, Olga V. Arjanova, Natalia D Prihoda, Aldar S. Bourinbaiar
Publikováno v:
Immunotherapy. 4:687-695
Aim: To evaluate the effect of an adjunct immunotherapy in randomized double-blind, placebo-controlled Phase IIb trial involving 123 TB patients. Methods: Patients were randomly allocated into two arms: one (n = 62) received a once-daily pill of V-5
Autor:
Vladimir V Mishchenko, Galyna A Kutsyna, Peter Nyasulu, Dmitry A Butov, Marina V Mezentseva, Vichai Jirathitikal, Yuri V Efremenko, Aldar S. Bourinbaiar
Publikováno v:
Expert Review of Anti-infective Therapy. 10:381-389
TB is typically caused by Mycobacterium tuberculosis, a symbiotic bacterium present in one-third of the world's population. There any many factors triggering overt clinical disease in a small proportion of humans. In our view the major role in the pr
Autor:
Vichai Jirathitikal, Nathalia D. Prihoda, Dendev Batdelger, Nina I. Sokolenko, Aldar S. Bourinbaiar, Marina G Tarakanovskaya, Olga V. Arjanova, Larisa V. Yurchenko, Valery M. Frolov
Publikováno v:
Immunotherapy. 3:181-191
This Phase IIb, placebo-controlled study involved 55 TB patients treated with anti-TB therapy. They were divided into two groups, matched by age, gender, baseline bodyweight and clinical manifestations: one group (n = 27) received a once-daily V-5 Im